We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$881M
AUM Growth
-$121M
Cap. Flow
-$139M
Cap. Flow %
-15.77%
Top 10 Hldgs %
39.5%
Holding
4,106
New
974
Increased
850
Reduced
839
Closed
1,374

Sector Composition

Rank Sector Weight
1 Technology 2.15%
2 Energy 2.14%
3 Industrials 2.11%
4 Financials 2.11%
5 Consumer Discretionary 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AD
2251
Array Digital Infrastructure
AD
$3.05B
$3K ﹤0.01%
81
-1,692
-95% -$65.5K
VOC icon
2252
VOC Energy
VOC
$50.3M
$3K ﹤0.01%
+715
New +$3.16K
ZYME icon
2253
Zymeworks
ZYME
$1.63B
$3K ﹤0.01%
+400
New +$4.48K
NAGE
2254
Niagen Bioscience
NAGE
$280M
$3K ﹤0.01%
+672
New +$2.13K
ATRI
2255
DELISTED
Atrion Corp
ATRI
$3K ﹤0.01%
5
-27
-84% -$14.5K
NEPT
2256
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$3K ﹤0.01%
2
NVTA
2257
DELISTED
Invitae Corporation
NVTA
$3K ﹤0.01%
304
-2,169
-88% -$21.4K
FRTX
2258
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$3K ﹤0.01%
4
+3
+300% +$2.19K
SVVC
2259
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$3K ﹤0.01%
305
+237
+349% +$1.98K
TRTN
2260
DELISTED
Triton International Limited
TRTN
$3K ﹤0.01%
100
-2,600
-96% -$76.8K
CYRN
2261
DELISTED
CYREN Ltd.
CYRN
$3K ﹤0.01%
73
-226
-76% -$9.36K
VIVO
2262
DELISTED
Meridian Bioscience Inc
VIVO
$3K ﹤0.01%
+200
New +$2.88K
ENDP
2263
DELISTED
Endo International plc
ENDP
$3K ﹤0.01%
+238
New +$2.79K
WVFC
2264
DELISTED
WVS Financial Corp
WVFC
$3K ﹤0.01%
+172
New +$2.63K
XLRN
2265
DELISTED
Acceleron Pharma
XLRN
$3K ﹤0.01%
+100
New +$2.9K
QADB
2266
DELISTED
QAD Inc. Class B
QADB
$3K ﹤0.01%
100
+50
+100% +$1.3K
CCRC
2267
DELISTED
China Customer Relations Centers, Inc
CCRC
$3K ﹤0.01%
+226
New +$3.42K
FPRX
2268
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$3K ﹤0.01%
+100
New +$3.12K
ZAGG
2269
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$3K ﹤0.01%
402
-2,721
-87% -$21.7K
TIF
2270
DELISTED
Tiffany & Co.
TIF
$3K ﹤0.01%
31
-68
-69% -$6.24K
CCR
2271
DELISTED
CONSOL Coal Resources LP
CCR
$3K ﹤0.01%
+200
New +$3.18K
GV
2272
DELISTED
Goldfield Corporation
GV
$3K ﹤0.01%
+600
New +$2.95K
FKO
2273
DELISTED
First Trust South Korea AlphaDEX Fund
FKO
$3K ﹤0.01%
+100
New +$2.61K
MSBF
2274
DELISTED
MSB Financial Corp.
MSBF
$3K ﹤0.01%
177
-37
-17% -$637
GNC
2275
DELISTED
GNC Holdings, Inc.
GNC
$3K ﹤0.01%
297
+97
+49% +$730

Similar funds

Tower Research Capital (TRC)'s Q2 2017 Portfolio in Review

As of Q2 2017, Tower Research Capital (TRC) held 4,106 positions worth $881M, down 12% from $1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tower Research Capital (TRC) withdrew a net $139M in Q2 2017, closing 1,374 positions and reducing 839 holdings. Its most notable exit was State Street SPDR S&P Retail ETF, an estimated $5.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.5% a quarter earlier, followed by Energy and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in State Street Consumer Discretionary Select Sector SPDR ETF worth $17.2M.

  • Tower Research Capital (TRC)'s largest Q2 2017 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 382,942 shares worth $17.2M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q2 2017, an estimated $60M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $152M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P Retail ETF in Q2 2017, selling an estimated $5.29M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 40% of its $881M portfolio in Q2 2017.
  • Tower Research Capital (TRC) opened 974 new positions and closed 1,374 in Q2 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 12% quarter-over-quarter to $881M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.